• Problem
  • Solution
  • Partners
  • Fellows
  • Portfolio
  • Team
  • Insights
    • Blog: Rock Island Review
    • News & Announcements
Ti-linkedin

News & Announcements

Research Bridge Partners and Lyda Hill Philanthropies Support Life Science Spinouts at UT Southwestern Medical Center

MorphImmune, Inc., a Research Bridge Partners Portfolio Company, Appoints Ronald Martell as President and CEO

Research Bridge Partners’ Portfolio Company, Novosteo, Inc., Closes $5.5 Million in Series A Financing

Research Bridge Partners’ Seed Capital Investment in Asalyxa Bio Advances Dr. Lola Eniola-Adefeso’s Immune Cell Targeted Therapeutic Platform

Research Bridge Partners Makes Seed Capital Investment In Erisyon, Inc.

Research Bridge Partners Makes Seed Investment in Eradivir, Inc.

Research Bridge Partners Makes Seed Capital Investment In Novosteo, Inc.

Research Bridge Partners Launches Seed Fund To Catalyze Commercialization Of Mid-Continent Research

About

  • Problem
  • Solution
  • Partners
  • Fellows
  • Portfolio
  • Problem
  • Solution
  • Partners
  • Fellows
  • Portfolio

Insights

  • Rock Island Review
  • News & Announcements
  • Rock Island Review
  • News & Announcements

Company

  • Team
  • Contact
  • Team
  • Contact

Connect

Linkedin

© 2023 Research Bridge Partners. All rights reserved

  • Problem
  • Solution
  • Partners
  • Fellows
  • Portfolio
  • Team
  • Insights
    • Blog: Rock Island Review
    • News & Announcements
 Twitter
 LinkedIn
 Email